ID
22464
Description
Study ID: 100273 Clinical Study ID: HS2100273 Study Title: A Randomized, Double-Blind, Placebo-Controlled, Multicenter 60-Day Study Comparing the Efficacy of Valtrex 1 Gram Once Daily vs. Placebo Once Daily in Reducing Viral Shedding in Immunocompetent Subjects with Recurrent HSV-2 Genital Herpes Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 4 Study Recruitment Status: Completed Generic Name: valaciclovir Trade Name: ZELITREX,Valtrex,RAPIVIR,Novirus Study Indication: Herpes Genitalis Visit description: Investigational Product
Mots-clés
Versions (1)
- 05/06/2017 05/06/2017 -
Téléchargé le
5 juin 2017
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY-NC 3.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
Efficacy of Valtrexin in Subjects with Recurrent HSV-2 Genital Herpes Study Investigational Product
Efficacy of Valtrexin in Subjects with Recurrent HSV-2 Genital Herpes Study Investigational Product
Description
Investigational Product Compliance
Alias
- UMLS CUI-1
- C0304229
- UMLS CUI-2
- C1321605
Description
Investigational Product
Type de données
text
Alias
- UMLS CUI [1]
- C0304229
Description
Date Investigational Product Dispensed
Type de données
date
Alias
- UMLS CUI [1,1]
- C0011008
- UMLS CUI [1,2]
- C0947323
- UMLS CUI [1,3]
- C0304229
Description
Number of Tablets Dispensed
Type de données
integer
Alias
- UMLS CUI [1,1]
- C0805077
- UMLS CUI [1,2]
- C0750480
- UMLS CUI [1,3]
- C0304229
Description
Date Investigational Product Returned
Type de données
date
Alias
- UMLS CUI [1,1]
- C0011008
- UMLS CUI [1,2]
- C0332156
- UMLS CUI [1,3]
- C0304229
Description
Number of Tablets Returned
Type de données
integer
Alias
- UMLS CUI [1,1]
- C2699071
- UMLS CUI [1,2]
- C0750480
- UMLS CUI [1,3]
- C0304229
Description
Investigational Product Discontinuation
Alias
- UMLS CUI-1
- C0304229
- UMLS CUI-2
- C0457454
Description
investigational product stopped
Type de données
text
Alias
- UMLS CUI [1,1]
- C0304229
- UMLS CUI [1,2]
- C0457454
Description
reason the investigational product was stopped
Type de données
integer
Alias
- UMLS CUI [1,1]
- C0392360
- UMLS CUI [1,2]
- C0304229
- UMLS CUI [1,3]
- C0457454
Description
reason the investigational product was stopped
Type de données
text
Alias
- UMLS CUI [1,1]
- C0392360
- UMLS CUI [1,2]
- C0304229
- UMLS CUI [1,3]
- C0457454
Similar models
Efficacy of Valtrexin in Subjects with Recurrent HSV-2 Genital Herpes Study Investigational Product
C0304229 (UMLS CUI [1,2])
C0304229 (UMLS CUI [1,2])
C1321605 (UMLS CUI-2)
C0947323 (UMLS CUI [1,2])
C0304229 (UMLS CUI [1,3])
C0750480 (UMLS CUI [1,2])
C0304229 (UMLS CUI [1,3])
C0332156 (UMLS CUI [1,2])
C0304229 (UMLS CUI [1,3])
C0750480 (UMLS CUI [1,2])
C0304229 (UMLS CUI [1,3])
C0457454 (UMLS CUI-2)
C0457454 (UMLS CUI [1,2])
C0304229 (UMLS CUI [1,2])
C0457454 (UMLS CUI [1,3])
C0304229 (UMLS CUI [1,2])
C0457454 (UMLS CUI [1,3])